Literature DB >> 15007728

Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene.

Joanne E Langan1, Charlotte G Cole, Elisabeth J Huckle, Shaun Byrne, Fiona E McRonald, Lynn Rowbottom, Anthony Ellis, Joan M Shaw, Irene M Leigh, David P Kelsell, Ian Dunham, John K Field, Janet M Risk.   

Abstract

Tylosis (focal non-epidermolytic palmoplantar keratoderma) is associated with the early onset of squamous cell oesophageal cancer in three families. Linkage and haplotype analyses have previously mapped the tylosis with oesophageal cancer ( TOC) locus to a 500-kb region on chromosome 17q25 that has also been implicated in sporadically occurring squamous cell oesophageal cancer. In the current study, 17 additional putative microsatellite markers were identified within this 500-kb region by using sequence data and seven of these were shown to be polymorphic in the UK and US families. In addition, our complete sequence analysis of the non-repetitive parts of the TOC minimal region identified 53 novel and six known single nucleotide polymorphisms (SNPs) in one or both of these families. Further fine mapping of the TOC disease locus by haplotype analysis of the seven polymorphic markers and 21 of the 59 SNPs allowed the reduction of the minimal region to 42.5 kb. One known and two putative genes are located within this region but none of these genes shows tylosis-specific mutations within their protein-coding regions. Alternative mechanisms of disease gene action must therefore be considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007728     DOI: 10.1007/s00439-004-1100-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  A sequence-ready BAC/PAC contig and partial transcript map of approximately 1.5 Mb in human chromosome 17q25 comprising multiple disease genes.

Authors:  G Kuhlenbäumer; A Schirmacher; J Meuleman; F Tissir; J Del-Favero; F Stögbauer; P Young; B Ringelstein; C Van Broeckhoven; V Timmerman
Journal:  Genomics       Date:  1999-12-01       Impact factor: 5.736

2.  Carcinoma of the oesophagus with keratosis palmaris et plantaris (tylosis): a study of two families.

Authors:  W HOWEL-EVANS; R B McCONNELL; C A CLARKE; P M SHEPPARD
Journal:  Q J Med       Date:  1958-07

Review 3.  Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas.

Authors:  H P Stevens; D P Kelsell; S P Bryant; D T Bishop; N K Spurr; J Weissenbach; D Marger; R S Marger; I M Leigh
Journal:  Arch Dermatol       Date:  1996-06

4.  Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC).

Authors:  D P Kelsell; J M Risk; I M Leigh; H P Stevens; A Ellis; H C Hennies; A Reis; J Weissenbach; D T Bishop; N K Spurr; J K Field
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

5.  Silver staining of native and denatured eucaryotic DNA in agarose gels.

Authors:  M Gottlieb; M Chavko
Journal:  Anal Biochem       Date:  1987-08-15       Impact factor: 3.365

6.  Working on the assembly line.

Authors:  R A Gibbs; M Cockerill
Journal:  Trends Biochem Sci       Date:  1995-04       Impact factor: 13.807

7.  Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25.

Authors:  J M Risk; C Ruhrberg; H Hennies; H S Mills; T Di Colandrea; K E Evans; A Ellis; F M Watt; D T Bishop; N K Spurr; H P Stevens; I M Leigh; A Reis; D P Kelsell; J K Field
Journal:  Genomics       Date:  1999-07-15       Impact factor: 5.736

8.  Palmoplantar keratoderma in association with carcinoma of the esophagus maps to chromosome 17q distal to the keratin gene cluster.

Authors:  H C Hennies; M Hagedorn; A Reis
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

9.  Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q.

Authors:  M von Brevern; M C Hollstein; J M Risk; J Garde; W P Bennett; C C Harris; K R Muehlbauer; J K Field
Journal:  Oncogene       Date:  1998-10-22       Impact factor: 9.867

10.  Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus.

Authors:  Janet M Risk; Kathryn E Evans; Joanne Jones; Joanne E Langan; Lyn Rowbottom; Fiona E McRonald; Helen S Mills; Anthony Ellis; Joan M Shaw; Irene M Leigh; David P Kelsell; John K Field
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

View more
  14 in total

1.  Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.

Authors:  Narayan Shivapurkar; Victor Stastny; Naoki Okumura; Luc Girard; Yang Xie; Clemens Prinsen; Frederik B Thunnissen; Ignacio I Wistuba; Bogdan Czerniak; Eugene Frenkel; Jack A Roth; Triantafillos Liloglou; George Xinarianos; John K Field; John D Minna; Adi F Gazdar
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 2.  Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family.

Authors:  Urszula Oleksiewicz; Triantafillos Liloglou; John K Field; George Xinarianos
Journal:  Cell Mol Life Sci       Date:  2011-07-09       Impact factor: 9.261

3.  Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer.

Authors:  Silva Saarinen; Pia Vahteristo; Rainer Lehtonen; Kristiina Aittomäki; Virpi Launonen; Tuula Kiviluoto; Lauri A Aaltonen
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  Duplication of Subcytoband 11E2 of Chromosome 11 Is Regularly Associated with Accelerated Tumor Development in v-abl/myc-Induced Mouse Plasmacytomas.

Authors:  Francis Wiener; Ann-Kristin Schmälter; Michael R A Mowat; Sabine Mai
Journal:  Genes Cancer       Date:  2010-08

5.  Rearrangements of the telomeric region of mouse chromosome 11 in Pre-B ABL/MYC cells revealed by mBANDing, spectral karyotyping, and fluorescence in-situ hybridization with a subtelomeric probe.

Authors:  Katalin Benedek; Ilse Chudoba; George Klein; Francis Wiener; Sabine Mai
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

6.  Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.

Authors:  R J Shaw; M M Omar; S Rokadiya; F A Kogera; D Lowe; G L Hall; J A Woolgar; J Homer; T Liloglou; J K Field; J M Risk
Journal:  Br J Cancer       Date:  2009-07-07       Impact factor: 7.640

7.  Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China.

Authors:  Zhang Guohong; Su Min; Wang Duenmei; Hu Songnian; Liu Min; Li Jinsong; Lin Hongbin; Zhang Feng; Tian Dongping; Yang Heling; Liu Zhicai; Lian Shiyong; Guo Quansheng; Li Xiaoyun; Gao Yuxia
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

8.  Selected telomere length changes and aberrant three-dimensional nuclear telomere organization during fast-onset mouse plasmacytomas.

Authors:  Alexandra Kuzyk; Sabine Mai
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

9.  RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

Authors:  Diana C Blaydon; Sarah L Etheridge; Janet M Risk; Hans-Christian Hennies; Laura J Gay; Rebecca Carroll; Vincent Plagnol; Fiona E McRonald; Howard P Stevens; Nigel K Spurr; D Timothy Bishop; Anthony Ellis; Janusz Jankowski; John K Field; Irene M Leigh; Andrew P South; David P Kelsell
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

10.  Protection from intracellular oxidative stress by cytoglobin in normal and cancerous oesophageal cells.

Authors:  Fiona E McRonald; Janet M Risk; Nikolas J Hodges
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.